Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) Files An 8-K Completion of Acquisition or Disposition of Assets
Item 2.01 Completion of Acquisition or Disposition of Assets.
KERYX BIOPHARMACEUTICALS INC Exhibit
EX-3.1 2 d670842dex31.htm EX-3.1 EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF KERYX BIOPHARMACEUTICALS,…
To view the full exhibit click here
